• Ph.D.(2008) Infectious Disease Control, Karolinska Institute and the Swedish Institute for Infectious Disease Control, Sweden
• Licentiate degree (2005) Infectious Disease Control, Karolinska Institute and the Swedish Institute for Infectious Disease Control, Sweden
• Master of science (2001) Molecular Cellbiology, Sodertorn University College, Sweden
• Employment:
  • 2008-present Postdoc, Los Alamos National Laboratory, Los Alamos, USA
  • 2002-2008 PhD student, Karolionska Institute and the Swedish Institute for Infectious Disease Control, Stockholm, Sweden
  • 2004-2008 GRA and HIV database annotation, Los Alamos National Laboratory, Los Alamos, USA
  • 2001-2002 Research Assistant, Swedish Institute for Infectious Disease Control, Stockholm, Sweden

Research Interests:

Selected Recent Publications:

1. Maljkovic Berry I, Ribeiro R, Kothari M, Athreya G, Daniels M, Lee HY, Bruno W, Leitner T., Unequal evolutionary rates in the HIV-1 pandemic: The evolutionary rate of HIV-1 slows down when the epidemic rate increases, Journal of Virology. 81,10625-10635 (2007)/span>.
2. van de Vijver DA, Wensing AMJ, Angarano G, Asjo B, Balotta C, Boeri E, Camacho R, Chaix M-L, Costagliola D, Op de Coul E, de Luca A, Maljkovic I, de Mendoza C, Derdelinckx I, Grossman Z, Hamouda O, Hatzakis A, Hoepelman IM, Hemmer R, Horban A, Korn K, Kucherer C, Leitner T, Loveday C, MacRae E, Meyer L, Nielsen C, Ormaasen V, Perrin L, Paraskevis D, Puchhammer-Stockl E, Ruiz L, Salminen MO, Schmit JCC, Schneider F, Schuurman R, Soriano V, Stanczak G, Stanojevic M, Vandamme A-M, Van Laethem K, Violin M, Wilbe K, Yerly S, Zazzi M, Boucher CAB, the SPREAD programme., The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes, Journal of Acquired Immune Deficiency Syndromes. 41,352-360 (2006)/span>.
3. Wensing AM, van de Vijver DA, Angarano G, Asjo B, Balotta C, Boeri E, Camacho R, Chaix M-L, Costagliola D, de Luca A, Derdelinckx I, Grossman Z, Hamouda O, Hatzakis A, Hemmer R, Hoepelamn A, Horban A, Korn K, Kucherer C, Leitner T, Loveday C, MacRae E, Maljkovic I, de Mendoza C, Meyer L, Nielsen C, Op de Coul E, Ormaasen V, Paraskevis D, Perrin L, Puchhammer-Stockl E, Ruiz L, Salminen M, Schmit J-C, Schneider F, Schuurman R, Soriano V, Stanczak G, Stanojevic M, Vandamme A-M, Van Laethem K, Violin M, Wilbe K, Yerly S, Zazzi M, Boucher CA; the SPREAD Programme., Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: Implications for clinical management, Journal of Infectious Diseases. 192,958-966 (2005)/span>.
4. Clevestig P, Maljkovic I, Casper C, Carlenor E, Lindgren S, Naver L, Bohlin AB, Fenyo EM, Leitner T, Ehrnst A., The X4 phenotype of HIV type 1 evolves from R5 in two children of mothers, carrying X4, and is not linked to transmission, AIDS Research and Human Retroviruses. 21,371-378 (2005)/span>.
5. Klingstrom J, Maljkovic I, Zuber B, Rollman E, Kjerrstrom A, Lundkvist A, Vaccination of C57/BL6 mice with Dobrava Hantavirus nucleocapsid protein in Freund's adjuvant induced partial protection against challenge, Vaccine. 22,4029-4034 (2004)/span>.
6. Tran TT, Maljkovic I, Swartling S, Phung DC, Chiodi F, Leitner T., HIV-1 CRF01_AE in intravenous drug users in Hanoi, Vietnam, AIDS Research and Human Retroviruses. 20,341-345 (2004)/span>.
7. Maljkovic I, Wilbe K, Solver E, Alaeus A, Leitner T., Limited transmission of drug-resistant HIV type 1 in 100 Swedish newly detected and drug-naive patients infected with subtypes A, B, C, D, G, U and CRF01_AE, AIDS Research and Human Retroviruses. 19,989-997 (2003)/span>.